Literature DB >> 22150794

The effect of intralesional injection of bone marrow derived mesenchymal stem cells and bone marrow supernatant on collagen fibril size in a surgical model of equine superficial digital flexor tendonitis.

C J Caniglia1, M C Schramme, R K Smith.   

Abstract

REASONS FOR PERFORMING STUDY: Collagen fibril size is decreased in repair tissue following tendon injury compared to normal tendon matrix in horses. Mesenchymal stem cells have been suggested to promote regeneration of tendon matrix rather than fibrotic repair following injury, although this concept remains unproven.
OBJECTIVES: To explore the hypothesis that implantation of autologous mesenchymal stem cells derived from bone marrow into a surgically created central core defect in the superficial digital flexor tendon (SDFT) of horses would induce the formation of a matrix with greater ultrastructural similarities to tendon matrix than the fibrotic scar tissue formed in control defects.
METHODS: Tissue was collected 16 weeks after induction of injury and 12 weeks after treatment from normal and injured regions of control and treated limbs of 6 horses and examined using transmission electron microscopy. Collagen fibril diameters were measured manually with image analysis software and surface areas calculated. Three parameters assessed for normal and injured tissue were mass average diameter (MAD), collagen fibril index (CFI) and the area dependent diameter (ADD).
RESULTS: Normal regions from both treated and control limbs displayed higher MAD and CFI values, as well as a characteristic bimodal distribution in fibril size. Injured regions from both treated and control limbs displayed significantly lower MAD and CFI values, as well as a unimodal distribution in fibril size. There were no significant differences between treated and control limbs for any of the parameters assessed.
CONCLUSIONS: Intralesional injection of autologous bone marrow derived mesenchymal stem cells had no measurable effect on the fibril diameter of collagen in healing tissue in the SDFT of this experimental model 16 weeks after injury. POTENTIAL RELEVANCE: Favouring matrix regeneration over fibrotic repair may not be the mechanism by which autologous mesenchymal stem cells assist healing of tendon injury.
© 2011 EVJ Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22150794     DOI: 10.1111/j.2042-3306.2011.00514.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  18 in total

1.  Effect of needle diameter on the viability of equine bone marrow derived mesenchymal stem cells.

Authors:  Hayley M Lang; Lauren V Schnabel; Jennifer M Cassano; Lisa A Fortier
Journal:  Vet Surg       Date:  2017-03-22       Impact factor: 1.495

2.  Growth Factor Roles in Soft Tissue Physiology and Pathophysiology.

Authors:  Jennifer H Roberts; Jaroslava Halper
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Stem cell therapy of tendinopathies: suggestions from veterinary medicine.

Authors:  Aurelio Muttini; Vincenzo Salini; Luca Valbonetti; Michele Abate
Journal:  Muscles Ligaments Tendons J       Date:  2012-10-16

4.  Comparative study on functional effects of allotransplantation of bone marrow stromal cells and adipose derived stromal vascular fraction on tendon repair: a biomechanical study in rabbits.

Authors:  Mehdi Behfar; Sara Javanmardi; Farshid Sarrafzadeh-Rezaei
Journal:  Cell J       Date:  2014-10-04       Impact factor: 2.479

5.  Evaluation of Autologous Protein Solution Injection for Treatment of Superficial Digital Flexor Tendonitis in an Equine Model.

Authors:  Angela M Gaesser; Claire Underwood; Renata L Linardi; Kayla M Even; Virginia B Reef; Snehal S Shetye; Robert L Mauck; William J King; Julie B Engiles; Kyla F Ortved
Journal:  Front Vet Sci       Date:  2021-07-05

6.  Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy.

Authors:  Roger Kenneth Whealands Smith; Natalie Jayne Werling; Stephanie Georgina Dakin; Rafiqul Alam; Allen E Goodship; Jayesh Dudhia
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

7.  Equine tendonitis therapy using mesenchymal stem cells and platelet concentrates: a randomized controlled trial.

Authors:  Armando de Mattos Carvalho; Peres Ramos Badial; Luis Emiliano Cisneros Álvarez; Ana Lucia Miluzzi Yamada; Alexandre Secorun Borges; Elenice Deffune; Carlos Alberto Hussni; Ana Liz Garcia Alves
Journal:  Stem Cell Res Ther       Date:  2013-07-22       Impact factor: 6.832

8.  Aspiration, but not injection, decreases cultured equine mesenchymal stromal cell viability.

Authors:  Lynn B Williams; Keith A Russell; Judith B Koenig; Thomas G Koch
Journal:  BMC Vet Res       Date:  2016-03-07       Impact factor: 2.741

9.  Response to Intravenous Allogeneic Equine Cord Blood-Derived Mesenchymal Stromal Cells Administered from Chilled or Frozen State in Serum and Protein-Free Media.

Authors:  Lynn B Williams; Carmon Co; Judith B Koenig; Crystal Tse; Emily Lindsay; Thomas G Koch
Journal:  Front Vet Sci       Date:  2016-07-22

10.  In vitro expansion impaired the stemness of early passage mesenchymal stem cells for treatment of cartilage defects.

Authors:  Tongmeng Jiang; Guojie Xu; Qiuyan Wang; Lihui Yang; Li Zheng; Jinmin Zhao; Xingdong Zhang
Journal:  Cell Death Dis       Date:  2017-06-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.